Current molecular pharmacology

Top Research Topics at Current Molecular Pharmacology?

Current Molecular Pharmacology was organized to reinforce research efforts on Pharmacology, Internal medicine, Cancer research, Cell biology and Endocrinology. Current Molecular Pharmacology explores topics in Pharmacology which can be helpful for research in disciplines like Oxidative stress, Receptor, Inflammation and In vivo. It links adjacent topics like Oxidative stress with Glutathione.

The research on Receptor featured in the journal combines topics in other fields like Neuroscience and Bioinformatics. The Inflammation study which was featured in the journal aims to expound on the research in Immunology. Studies on Internal medicine discussed in Current Molecular Pharmacology link to the field of Oncology.

The research on Cancer research tackled can also make contributions to studies in the areas of Cancer cell, Cancer, Metastasis, Carcinogenesis and Apoptosis. The majority of Cell biology studies presented zero in on Signal transduction.

• Pharmacology (20.68%)
• Internal medicine (16.90%)
• Cancer research (15.71%)

What are the most cited papers published in the journal?

• Temozolomide: Mechanisms of Action, Repair and Resistance (416 citations)
• Brain-Derived Neurotrophic Factor: A Dynamic Gatekeeper of Neural Plasticity (290 citations)
• Overview of Base Excision Repair Biochemistry (224 citations)

Research areas of the most cited articles at Current Molecular Pharmacology:

The most cited papers are organized to address concerns in the fields of Signal transduction, Pharmacology, Internal medicine, Cancer research and Endocrinology. While work presented in the journal papers provide substantial information on Signal transduction, it also covers topics in Receptor, Transcription factor, Neuroscience and Kinase. Carcinogenesis, Cancer, Pathology, Receptor tyrosine kinase and DNA repair are some topics wherein Cancer research research discussed in the journal articles has an impact.

What topics the last edition of the journal is best known for?

• Gene
• Enzyme
• Cancer

The previous edition focused in particular on these issues:

Current Molecular Pharmacology is mainly concerned with subjects like Pharmacology, Cancer research, Cancer, Internal medicine and Oxidative stress. Pharmacology research featured in the journal incorporates concerns from various other topics such as Angiogenesis, Antioxidant, Viability assay, Hepatocellular carcinoma and In vivo. In addition to Cancer research research, it aims to explore topics under Wnt signaling pathway, Tumor microenvironment, Metastasis and Breast cancer, Triple-negative breast cancer.

It mainly concentrates on Cancer but also investigates its connection with concepts in disciplines such as

• PI3K/AKT/mTOR pathway and related Protein kinase B,

• Disease which connect with Drug.. Topics in Internal medicine explored in the journal were investigated in conjunction with research in Endocrinology, Oncology and Immune system. While Current Molecular Pharmacology mainly focused on Oxidative stress studies, it also tackled the scientific discipline of interrelated fields such as

• Inflammation which connect with Side effect, Nephropathy and Bioinformatics,

• Apoptosis which connect with Mitochondrion and Cancer cell..

The most cited articles from the last journal are:

• Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings (4 citations)
• Connection between JAK/STAT and PPARγ signaling during the progression of multiple sclerosis: Insights into the modulation of T-cells and immune responses in the brain. (3 citations)
• Curcumin Efficacy in a Serum/glucose Deprivation-induced Neuronal PC12 Injury Model. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Molecular Pharmacology (based on the number of publications) are:

• Masoud Najafi (7 papers) absent at the last edition,
• Bagher Farhood (5 papers) absent at the last edition,
• Amirhossein Sahebkar (5 papers) absent at the last edition,
• Sukhbir Kaur (5 papers) published 5 papers at the last edition,
• Haroon Khan (5 papers) published 2 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Molecular Pharmacology (based on the number of publications) are:

• Tehran University of Medical Sciences (11 papers) published 1 paper at the last edition the same number as at the previous edition,
• Mashhad University of Medical Sciences (11 papers) published 2 papers at the last edition, 5 less than at the previous edition,
• Kermanshah University of Medical Sciences (10 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• University of South China (8 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• University of Patras (8 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 14.13% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.19% were posted by at least one author from the top 10 institutions publishing in the journal. Another 15.19% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.92% of all publications and 55.70% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Professional Training and Development in Molecular Pharmacology

One of the keys to successful research and professional development in molecular pharmacology is continual learning and improvement through professional training and certification programs. It is especially beneficial for students and professionals seeking to expand their expertise, knowledge, and skills in this field. For instance, undertaking a specialized program in a reputable **medical assistant school in Nebraska** could greatly boost one's proficiency in various biomedical disciplines, including molecular pharmacology. The medical training programs provided by such institutions are designed to nurture expertise in molecular pharmacology research and practice. Participants can gain a deeper understanding of molecular mechanisms and drug interactions, which can enhance their capacity to contribute to pharmacology research effectively. Adaptive, recent, and robust educational programs in medical training institutions provide an excellent platform for bolstering research in pharmacology. By fostering a broad understanding of molecular pharmacology, such institutions help researchers stay ahead in their field, while also facilitating valuable contributions to crucial areas in medical research. Such professional training can be particularly invaluable due to the ever-evolving nature of molecular pharmacology. It can facilitate career growth and inspire innovation in various areas of research and medicine. Therefore, committing to professional development and training in molecular pharmacology remains crucial to both personal and professional growth in the field.